N-Phenethyl-14-ethoxymetopon
From Wikipedia, the free encyclopedia
|
N-Phenethyl-14-ethoxymetopon
|
|
| Systematic (IUPAC) name | |
| 3-hydroxy-14-ethoxy-5-methyl-7,8-dihydro-4,5α-epoxy-17-(2-phenylethyl)morphinan-6-one | |
| Identifiers | |
| CAS number | ? |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C27H31NO4 |
| Mol. mass | 433.538 g/mol |
| SMILES | & |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
N-Phenethyl-14-ethoxymetopon is a drug which is a derivative of metopon. It is a potent analgesic, around 60 times stronger than morphine, but produces significantly less constipation.[1]
N-Phenethyl-14-ethoxymetopon acts as an agonist at both μ- and δ-opioid receptors, with a Ki of 0.16nM at μ and 3.14nM at δ.[2]
[edit] References
- ^ Ananthan S. Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS Journal. 2006 Mar 10;8(1):E118-25. PMID 16584118
- ^ Lattanzi R, Spetea M, Schüllner F, Rief SB, Krassnig R, Negri L, Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 22.(1) Influence of the 14-alkoxy group and the substitution in position 5 in 14-alkoxymorphinan-6-ones on in vitro and in vivo activities. Journal of Medicinal Chemistry. 2005 May 5;48(9):3372-8. PMID 15857143

